Seagen Inc. Insider Trading for September 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for September 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.29 | 2,249 | 23,142 | 30,000 | |
| Sep 23 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 56.75 | 2,249 | 127,631 | 113,255 | 115.5 K to 113.3 K (-1.95 %) |
| Sep 23 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.29 | 2,249 | 23,142 | 115,504 | 113.3 K to 115.5 K (+1.99 %) |
| Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.00 | 300 | 3,600 | 0 | |
| Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.00 | 22,618 | 271,416 | 300 | |
| Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 54.41 | 300 | 16,324 | 87,767 | 88.1 K to 87.8 K (-0.34 %) |
| Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.00 | 300 | 3,600 | 88,067 | 87.8 K to 88.1 K (+0.34 %) |
| Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 54.03 | 22,618 | 1,222,146 | 87,767 | 110.4 K to 87.8 K (-20.49 %) |
| Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.00 | 22,618 | 271,416 | 110,385 | 87.8 K to 110.4 K (+25.77 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 51.55 | 24,339 | 1,254,571 | 39,432,496 | 39.4 M to 39.4 M (+0.06 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 51.55 | 2,730 | 140,720 | 4,715,898 | 4.7 M to 4.7 M (+0.06 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 51.41 | 58,541 | 3,009,341 | 39,408,157 | 39.3 M to 39.4 M (+0.15 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 51.41 | 6,565 | 337,478 | 4,713,168 | 4.7 M to 4.7 M (+0.14 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.64 | 899 | 45,523 | 39,349,616 | 39.3 M to 39.3 M (0.00 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.64 | 101 | 5,114 | 4,706,603 | 4.7 M to 4.7 M (0.00 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.42 | 21,804 | 1,099,388 | 39,348,717 | 39.3 M to 39.3 M (+0.06 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.42 | 2,445 | 123,280 | 4,706,502 | 4.7 M to 4.7 M (+0.05 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.41 | 21,290 | 1,073,191 | 39,326,913 | 39.3 M to 39.3 M (+0.05 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.41 | 2,388 | 120,375 | 4,704,057 | 4.7 M to 4.7 M (+0.05 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.00 | 90 | 4,500 | 39,305,623 | 39.3 M to 39.3 M (0.00 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.00 | 10 | 500 | 4,701,669 | 4.7 M to 4.7 M (0.00 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 49.84 | 899 | 44,802 | 39,305,533 | 39.3 M to 39.3 M (0.00 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 49.84 | 101 | 5,033 | 4,701,659 | 4.7 M to 4.7 M (0.00 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.99 | 8,380 | 427,266 | 39,304,634 | 39.3 M to 39.3 M (+0.02 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.99 | 940 | 47,927 | 4,701,558 | 4.7 M to 4.7 M (+0.02 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.48 | 2,338 | 118,029 | 39,296,254 | 39.3 M to 39.3 M (+0.01 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.48 | 262 | 13,227 | 4,700,618 | 4.7 M to 4.7 M (+0.01 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 51.25 | 33,241 | 1,703,751 | 39,293,916 | 39.3 M to 39.3 M (+0.08 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 51.25 | 3,728 | 191,077 | 4,700,356 | 4.7 M to 4.7 M (+0.08 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.33 | 23,440 | 1,179,656 | 39,260,675 | 39.2 M to 39.3 M (+0.06 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.33 | 2,637 | 132,711 | 4,696,628 | 4.7 M to 4.7 M (+0.06 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.38 | 170,652 | 8,597,226 | 39,237,235 | 39.1 M to 39.2 M (+0.44 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.38 | 19,201 | 967,321 | 4,693,991 | 4.7 M to 4.7 M (+0.41 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 51.05 | 7,944 | 405,541 | 39,066,583 | 39.1 M to 39.1 M (+0.02 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 51.05 | 894 | 45,639 | 4,674,790 | 4.7 M to 4.7 M (+0.02 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.55 | 28,271 | 1,428,963 | 39,058,639 | 39 M to 39.1 M (+0.07 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.55 | 3,181 | 160,784 | 4,673,896 | 4.7 M to 4.7 M (+0.07 %) |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 15.46 | 4,167 | 64,422 | 0 | |
| Sep 13 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 15.46 | 4,167 | 64,422 | 55,743 | 51.6 K to 55.7 K (+8.08 %) |
| Sep 12 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 31,269 | 321,758 | 115,443 | |
| Sep 12 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Gift | G | 0.00 | 6,148 | 0 | 0 | 6.1 K to 0 (-100.00 %) |
| Sep 12 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 50.08 | 31,269 | 1,565,977 | 638,835 | 670.1 K to 638.8 K (-4.67 %) |
| Sep 12 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 31,269 | 321,758 | 648,307 | 617 K to 648.3 K (+5.07 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 4,042 | 41,228 | 31,533 | |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 4.45 | 5,411 | 24,079 | 0 | |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 4.45 | 2,200 | 9,790 | 5,411 | |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 1,973 | 20,302 | 0 | |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 10,331 | 105,376 | 0 | |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 45.91 | 5,411 | 248,432 | 617,038 | 622.4 K to 617 K (-0.87 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 4.45 | 5,411 | 24,079 | 622,449 | 617 K to 622.4 K (+0.88 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 45.15 | 2,200 | 99,335 | 617,038 | 619.2 K to 617 K (-0.36 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 4.45 | 2,200 | 9,790 | 619,238 | 617 K to 619.2 K (+0.36 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 44.84 | 4,042 | 181,240 | 617,038 | 621.1 K to 617 K (-0.65 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 4,042 | 41,228 | 621,080 | 617 K to 621.1 K (+0.66 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 1,973 | 20,302 | 617,038 | 615.1 K to 617 K (+0.32 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 10,331 | 105,376 | 615,065 | 604.7 K to 615.1 K (+1.71 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Option Exercise | M | 10.20 | 10,000 | 102,000 | 0 | |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Buy | M | 10.20 | 10,000 | 102,000 | 37,650 | 27.7 K to 37.7 K (+36.17 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 46.02 | 771 | 35,479 | 51,576 | 52.3 K to 51.6 K (-1.47 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 46.01 | 4,626 | 212,828 | 52,347 | 57 K to 52.3 K (-8.12 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.48 | 33,893 | 1,710,844 | 39,030,368 | 39 M to 39 M (+0.09 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.48 | 3,813 | 192,472 | 4,670,715 | 4.7 M to 4.7 M (+0.08 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.10 | 48,036 | 2,406,829 | 38,996,475 | 38.9 M to 39 M (+0.12 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.10 | 5,405 | 270,816 | 4,666,902 | 4.7 M to 4.7 M (+0.12 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.05 | 101,290 | 5,069,433 | 38,948,439 | 38.8 M to 38.9 M (+0.26 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 50.05 | 11,397 | 570,405 | 4,661,497 | 4.7 M to 4.7 M (+0.25 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 49.46 | 5,581 | 276,030 | 38,847,149 | 38.8 M to 38.8 M (+0.01 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 49.46 | 628 | 31,060 | 4,650,100 | 4.6 M to 4.7 M (+0.01 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 49.18 | 944 | 46,427 | 38,841,568 | 38.8 M to 38.8 M (0.00 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 49.18 | 106 | 5,213 | 4,649,472 | 4.6 M to 4.6 M (0.00 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.61 | 13,825 | 672,033 | 38,840,624 | 38.8 M to 38.8 M (+0.04 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.61 | 1,556 | 75,637 | 4,649,366 | 4.6 M to 4.6 M (+0.03 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.95 | 12,955 | 634,191 | 38,826,799 | 38.8 M to 38.8 M (+0.03 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.95 | 1,457 | 71,325 | 4,647,810 | 4.6 M to 4.6 M (+0.03 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 47.27 | 548 | 25,904 | 38,813,844 | 38.8 M to 38.8 M (0.00 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 47.27 | 62 | 2,931 | 4,646,353 | 4.6 M to 4.6 M (0.00 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.16 | 11,681 | 562,550 | 38,813,296 | 38.8 M to 38.8 M (+0.03 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.16 | 1,314 | 63,281 | 4,646,291 | 4.6 M to 4.6 M (+0.03 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.44 | 8,598 | 416,460 | 38,801,615 | 38.8 M to 38.8 M (+0.02 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.44 | 967 | 46,838 | 4,644,977 | 4.6 M to 4.6 M (+0.02 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.29 | 5,930 | 286,332 | 38,793,017 | 38.8 M to 38.8 M (+0.02 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.29 | 667 | 32,206 | 4,644,010 | 4.6 M to 4.6 M (+0.01 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 46.17 | 84,331 | 3,893,638 | 4,643,343 | 4.6 M to 4.6 M (+1.85 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 45.10 | 3,600 | 162,369 | 4,559,012 | 4.6 M to 4.6 M (+0.08 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 45.39 | 35,263 | 1,600,457 | 4,555,412 | 4.5 M to 4.6 M (+0.78 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 46.10 | 8,360 | 385,414 | 4,520,149 | 4.5 M to 4.5 M (+0.19 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 44.98 | 2,735 | 123,025 | 4,511,789 | 4.5 M to 4.5 M (+0.06 %) |
| Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 45.80 | 9,074 | 415,623 | 4,509,054 | 4.5 M to 4.5 M (+0.20 %) |
| Sep 01 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Grant | A | 0.00 | 9,600 | 0 | 135,379 | 125.8 K to 135.4 K (+7.63 %) |